Bone Biologics Corp Quarterly Return On Equity in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bone Biologics Corp quarterly/annual Return On Equity history and growth rate from Q3 2013 to Q3 2024.
  • Bone Biologics Corp Return On Equity for the quarter ending September 30, 2024 was -125 %, a 12.8% increase year-over-year.
  • Bone Biologics Corp annual Return On Equity for 2023 was -236 %, a 773% decline from 2022.
  • Bone Biologics Corp annual Return On Equity for 2022 was -27 %, a 256% decline from 2021.
  • Bone Biologics Corp annual Return On Equity for 2021 was 17.3 %, a 23.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -125 +18.2 +12.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -154 -30.7 -24.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -152 -55.7 -57.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -236 -209 -773% Oct 1, 2023 Dec 31, 2023
Q3 2023 -143 -97.7 -216% Jul 1, 2023 Sep 30, 2023
Q2 2023 -123 +117 +48.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -96.3 -140 -321% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27 -44.3 -256% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.2 -58.3 -445% Jul 1, 2022 Sep 30, 2022
Q2 2022 -240 -253 -1985% Apr 1, 2022 Jun 30, 2022
Q1 2022 43.6 +31.3 +254% Jan 1, 2022 Mar 31, 2022
Q4 2021 17.3 +3.31 +23.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 13.1 -1.98 -13.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 12.7 -4.32 -25.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 12.3 -10.2 -45.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 14 -17.1 -55.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 15.1 -27.7 -64.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 17.1 -27.2 -61.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 22.5 -27.3 -54.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 31.1 -21.4 -40.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 42.8 -25.5 -37.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 44.2 -41.8 -48.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 49.8 -10.9 -18% Jan 1, 2019 Mar 31, 2019
Q4 2018 52.5 -25.7 -32.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 68.3 -31.3 -31.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 86 -45.8 -34.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 60.7 -171 -73.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 78.1 -354 -81.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 99.6 -491 -83.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 132 -623 -82.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 232 -700 -75.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 433 -34.7 -7.42% Oct 1, 2016 Dec 31, 2016
Q3 2016 590 +346 +141% Jul 1, 2016 Sep 30, 2016
Q2 2016 755 +571 +311% Apr 1, 2016 Jun 30, 2016
Q1 2016 931 +810 +664% Jan 1, 2016 Mar 31, 2016
Q4 2015 467 +344 +278% Oct 1, 2015 Dec 31, 2015
Q3 2015 245 +162 +195% Jul 1, 2015 Sep 30, 2015
Q2 2015 183 +150 +451% Apr 1, 2015 Jun 30, 2015
Q1 2015 122 +61.1 +101% Jan 1, 2015 Mar 31, 2015
Q4 2014 124 +85.4 +223% Oct 1, 2014 Dec 31, 2014
Q3 2014 83 +37.3 +81.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 33.3 Apr 1, 2014 Jun 30, 2014
Q1 2014 60.8 Jan 1, 2014 Mar 31, 2014
Q4 2013 38.3 Nov 1, 2013 Jan 31, 2014
Q3 2013 45.7 Jul 1, 2013 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.